Home > Healthcare > Medical Devices > Infection Control > Personal Protective Equipment for Infection Control Market
Personal Protective Equipment for Infection Control Market Size
Personal Protective Equipment for Infection Control Market size surpassed USD 24 billion in 2022. The industry is set to exhibit over 2% CAGR through 2023-2032, given the surging elderly population and elective surgical procedures.
With the world’s older population growing at a rapid pace, the occurrence of chronic disease continues to rise. According to data from the CDC, 6 in 10 U.S. adults are diagnosed with chronic health conditions, boosting the requirement for surgical procedures for disease treatment. Apart from emergency procedures, the rate of elective surgeries has also risen. These factors will escalate the adoption of PPE in infection control to safeguard healthcare personnel and patients from body fluids, microorganisms, and particulate matter.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 24 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 2% |
| 2032 Value Projection: | USD 26.5 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 212 |
| Segments covered: | Product, Usability, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Despite the positive business environment, the development of advanced machinery, fabrics, and skilled laborers to ensure uninterrupted PPE supply has become a challenge. The ever-increasing demand has also led to higher raw material costs, hindering the usage of masks and other personal protective equipment in healthcare settings. However, rapid technological advancements and the extensive availability of non-invasive surgical options are likely to create opportunities for industry expansion.
Personal Protective Equipment for Infection Control Market Analysis
Personal protective equipment for infection control market size from the face protection equipment product segment crossed USD 8.5 billion by 2032. The rising export of respiratory supplies to nations with fragile economic and medical systems will drive face mask production. In January 2022, the export of therapeutic respiration equipment including face masks from China to North Korea gained momentum, with trade valued at USD 2,769. Additionally, the capability to limit infections due to airborne bacteria, dust, and other pathogens will stimulate overall product consumption.
Based on usability, the reusable segment accounted for over 23% share of the personal protective equipment for infection control market in 2022, considering the product’s high sustainability and affordability. The increasing awareness about the generation of single-use gown waste and its contribution to the medical waste disposal issue has grown, resulting in a shift toward reusable counterparts. Since waste management has become a major concern for healthcare facilities, the adoption of reusable personal protective equipment in hospitals is expected to rise considerably in the upcoming years.
Personal protective equipment for infection control market from the research and diagnostic laboratories segment will reach over USD 5 billion by 2032, given the increase in clinical research funding. For instance, in November 2022, Tennessee-based Oak Ridge National Laboratory received funding worth USD 497 million under the Inflation Reduction Act signed into law in August. This funding was intended for scientific research and other programs, thus bolstering the usage of PPE to reduce infections. Furthermore, the need to improve infectious disease diagnosis will bolster the use of personal protective equipment for infection control in research and diagnostic labs.
Europe personal protective equipment for infection control market size is expected to be worth over USD 6 billion by 2032, on account of the increasing incidence of infectious diseases. This growing burden of infectious diseases and the escalating R&D efforts toward the development of advanced treatments will amplify the production of PPE for infection control across the region.
Personal Protective Equipment for Infection Control Market Share
The competitive landscape of the personal protective equipment for infection control market comprises companies such as
- Kimberly-Clark Corporation
- SHIELD Scientific
- Medline Industries Inc.
- Cardinal Health, Inc.
- B. Braun Melsungen AG
- CleanSpace Technology
- Dragerwerk AG
- SAS Safety Corp.
- Gateway Safety
- Ansell
- Alpha Pro Tech Limited
- The M Company
- Honeywell International
These firms are focusing on product range expansions, partnerships, and other strategies to reinforce their presence in the global industry.
Impact of COVID-19 Pandemic
Since the onset of the COVID-19 pandemic, the global population has been emphasizing various infection control strategies to curb viral transmission. In recent years, the number of casualties due to the virus has surged. As per the WHO’s report, as of January 2023, there have been nearly 655 million confirmed cases and 6 million deaths associated with the COVID-19 disease. These factors will proliferate the demand for personal protective equipment among COVID-19 patients and consequently augment market share over the foreseeable future.
The personal protective equipment for infection control market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product
- Hand and arm protection equipment
- Gloves
- Elbow protectors
- Others
- Protective clothing
- Full body suits
- Surgical gowns
- Vests
- Others
- Face protection equipment
- Respirators and face masks
- Shields
- Eyewear
- Others
- Others
By Usability
- Disposable
- Reusable
By End-use
- Hospitals
- Ambulatory surgical centers
- Research and diagnostic laboratories
- Others
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Turkey
- The Netherlands
- Switzerland
- Others
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Others
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- Qatar
- Others
Frequently Asked Questions (FAQ) :